14,191 Shares in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Acquired by Verdence Capital Advisors LLC

Verdence Capital Advisors LLC bought a new position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 14,191 shares of the company's stock, valued at approximately $430,000.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Signaturefd LLC raised its position in Acadia Healthcare by 460.6% during the 4th quarter. Signaturefd LLC now owns 1,222 shares of the company's stock valued at $48,000 after purchasing an additional 1,004 shares during the last quarter. Quadrant Capital Group LLC boosted its stake in Acadia Healthcare by 287.1% during the 4th quarter. Quadrant Capital Group LLC now owns 1,258 shares of the company's stock valued at $50,000 after purchasing an additional 933 shares during the last quarter. UMB Bank n.a. boosted its stake in Acadia Healthcare by 149.5% during the 1st quarter. UMB Bank n.a. now owns 1,260 shares of the company's stock valued at $38,000 after purchasing an additional 755 shares during the last quarter. State of Wyoming bought a new position in Acadia Healthcare in the fourth quarter valued at about $56,000. Finally, Covestor Ltd lifted its position in Acadia Healthcare by 27.2% during the fourth quarter. Covestor Ltd now owns 1,450 shares of the company's stock valued at $58,000 after purchasing an additional 310 shares in the last quarter.

Acadia Healthcare Stock Performance

Shares of ACHC traded up $0.93 during mid-day trading on Wednesday, reaching $22.97. The company had a trading volume of 1,303,603 shares, compared to its average volume of 1,873,874. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 0.72. Acadia Healthcare Company, Inc. has a 52-week low of $20.36 and a 52-week high of $82.41. The stock has a 50 day moving average of $22.89 and a two-hundred day moving average of $29.85. The stock has a market capitalization of $2.12 billion, a P/E ratio of 11.32, a PEG ratio of 4.20 and a beta of 0.93.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last announced its earnings results on Monday, May 12th. The company reported $0.40 EPS for the quarter, beating analysts' consensus estimates of $0.35 by $0.05. Acadia Healthcare had a return on equity of 8.72% and a net margin of 5.94%. The business had revenue of $770.51 million during the quarter, compared to analysts' expectations of $769.90 million. During the same quarter in the prior year, the firm earned $0.84 earnings per share. The business's revenue was up .3% compared to the same quarter last year. On average, analysts expect that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on the company. Stephens raised Acadia Healthcare to a "hold" rating in a research note on Monday, June 2nd. Barclays cut their target price on Acadia Healthcare from $35.00 to $28.00 and set an "equal weight" rating on the stock in a research note on Wednesday, May 14th. Guggenheim began coverage on Acadia Healthcare in a research report on Wednesday, April 9th. They set a "buy" rating and a $36.00 target price for the company. Wall Street Zen raised Acadia Healthcare from a "sell" rating to a "hold" rating in a research report on Thursday, May 22nd. Finally, Mizuho reduced their target price on Acadia Healthcare from $37.00 to $32.00 and set a "neutral" rating on the stock in a research report on Wednesday, May 14th. Five equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $47.94.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.